Trial intelligence / Profile preview

Effects of Cannabis on Cancer Burden

NCT06601218Phase 1Recruiting

Start
Jun 2025
Primary completion
Dec 2029
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of cannabis in solid tumor (4 arms). Primary endpoint: Percent of participants that withdraw from the study or are removed due to adverse events at 5.5 months. Started Jun 2025; status: recruiting.

02

Drugs

cannabis
03

Conditions

solid tumor

Beyond the preview

Go deeper on NCT06601218.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06601218.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call